Hologic Inc. buy stepdown
Start price
31.12.20
/
80%
€60.00
Target price
31.12.21
€78.00
Performance (%)
10.17%
End price
01.01.22
€66.10
Summary
This prediction ended on 01.01.22 with a price of €66.10. The BUY prediction by stepdown finished with a performance of 10.17%. stepdown has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hologic Inc. | 0.704% | 0.704% | -5.995% | 31.386% |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% | 16.075% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% | 46.938% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% | 4.643% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% | 42.418% |
According to stepdown what are the pros and cons of Hologic Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Top Rating
High Investments for future growth
Very positive Cash Flow expected
Valuable balance sheet
ROE higher than 10% per year
Small challenges to pay loans and raise capital
Fair valuation
Capable Management
Good culture
Some uniques
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Known brand
Small cyclical dependencies
Cons
Comments by stepdown for this prediction
In the thread Hologic Inc. diskutieren
Kursziel geändert auf 78,0
In the thread Trading Hologic Inc.
Die von stepdown gewählte maximale Laufzeit wurde überschritten